beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1) (Middle Region) Peptid
B4GALNT1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle B4GALNT1 Produkte
- B4GALNT1 (beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- GLGSLRVGSC SDVVVDHASK LKLPWTSRDA GAETYARYRY PGSLDESQMA
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-B4GALNT1 Antibody(ARP45118_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- B4GALNT1 (beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1))
- Hintergrund
-
GM2 and GD2 gangliosides are sialic acid-containing glycosphingolipids. GalNAc-T is the enzyme involved in the biosynthesis of G(M2) and G(D2) glycosphingolipids. B4GALNT1(GalNAc-T) catalyzes the transfer of GalNAc into G(M3) and G(D3) by a beta-1,4 linkage, resulting in the synthesis of G(M2) and G(D2), respectively.
Alias Symbols: GALGT, GALNACT
Protein Interaction Partner: B4GALNT1,B4GALNT1
Protein Size: 533 - Molekulargewicht
- 59 kDa
- Gen-ID
- 2583
- NCBI Accession
- NM_001478, NP_001469
- UniProt
- Q00973
-
Sie sind hier:
